The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney Function
CONCLUSION: Saliva levels can be used to predict atomoxetine pharmacological response.